| | Pathology and Molecular Medicine | | |
| | ChangeRemoveSave | Add | Add |
| School | Queen's School of Medicine | | |
| Location | Kingston, ON, Canada | | |
| School Type | Medical School | | |
| School Size | Full-time Undergraduate: 200
| | |
| Degree | Master | | |
| Honours | | | |
| Co-op | | | |
| Length | 2 Year(s) | | |
| Entry Grade (%)* | | | |
| Prerequisites | | | |
| Prerequisites Notes | Applicants are required to have an Honours B.Sc. or equivalent in life sciences, biochemistry, biology, etc. (Students with only a general degree can be admitted for a qualifying year.). The ideal undergraduate background for the program would be one rich in molecular genetics and cell biology, in addition to foundational courses in Chemistry, Mathematics, Physiology, Biology and Biochemistry. The Queen’s Life Sciences and DBMS programs, or similar programs from other institutions provide excellent backgrounds. | | |
| Cost |
This cost estimate is for Year 1 of the program, and does not include supplementary fees. | | |
| Scholarships | | | |
| Description | The Department of Pathology and Molecular Medicine is a clinical department with a major research focus in cancer, hemostasis and vascular biology. Trainees therefore have opportunities to pursue comprehensive training in basic and translational biomedical research, an example being diagnostic, predictive and prognostic biomarker research. The graduate programs offer opportunities to pursue advanced degrees under the supervision of an exceptional group of basic, clinical and translational researchers.
With a focus on cancer – 15 of our 20 investigators are cancer biologists – our department members deliver comprehensive diagnostic laboratory and clinical services to Southeastern Ontario through the Kingston General Hospital, offering great training for the next generation of biomedical research scientists and laboratory physicians. Queen's therefore is a great setting to learn first-hand how the fast pace of molecular genetic research is changing clinical practise, leading to exciting new diagnostic and treatment approaches for cancer and other diseases. | | |
| Next Steps | | | |